Feasibility Study of MET-4: Evaluating Fecal Microbiome Effects in Immunotherapy Patients
Feasibility Study of MET-4: Evaluating Fecal Microbiome Effects in Immunotherapy Patients
Active, not recruiting · NCT03686202 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Feasibility Study of MET-4: Evaluating Fecal Microbiome Effects in Immunotherapy Patients | All Solid Tumors | Active, not recruiting | Phase 2 / Phase 3 | 2026-10-05 | NCT03686202 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| NuBiyota | 1 |
| University Health Network, Toronto | 417 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Princess Margaret Cancer Centre | Toronto | Canada | 145 |